Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518481 | 1.00 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL6826969 | 1.00 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL10888853 | 1.00 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL8471546 | 0.96 | — | — | |
| SCHEMBL21359710 | 0.96 | — | — | |
| SCHEMBL22440524 | 0.96 | — | — | |
| SCHEMBL19900042 | 0.96 | — | — | |
| SCHEMBL284693 | 0.96 | — | — | |
| SCHEMBL11658893 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL6032222 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103675273-B | A kind of CDV antigen chemiluminescence detection kit | LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD. (CN) | 2015-12-09 | — | — | CN | claimed |
| CN-103675273-A | Chemiluminiscence detection kit for canine distemper virus antigen | LUOYANG LAIPSON INFORMATION TECHNOLOGY CO LTD | 2014-03-26 | — | — | CN | claimed |
| US-20120006239-A1 | PROCESS FOR OPERATING A COAL-FIRED UTILITY BOILER | ENVIORMENTAL ENERGY SERVICES, INC. | 2012-01-12 | — | — | US | claimed |
| US-20110269079-A1 | PROCESS FOR OPERATING A UTILITY BOILER AND METHODS THEREFOR | ENVIROMENTAL ENERGY SERVICES, INC. | 2011-11-03 | — | — | US | claimed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-4644394-A2 | ANTIVIRAL COMPOUNDS | Gilead Sciences, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4106876-B1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250002513-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-01-02 | — | — | US | disclosed |
| US-12030903-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| CN-115571913-B | Method for recycling vanadium resources in vanadium liquid silicon removal slag | 攀钢集团攀枝花钢铁研究院有限公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-4106876-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2022-12-28 | — | — | EP | disclosed |
| US-20220289734-A1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | LES LABORATOIRES SERVIER (FR) | 2022-09-15 | — | — | US | disclosed |
| WO-2005007792-A1 | A PROCESS FOR PRODUCING A POWDER CONSISTING OF SODIUMSESQUICARBONATE AND LAYERED SILICATE | CLENVI CO., LTD. (KR) | 2005-01-27 | — | — | WO | disclosed |
| CN-1542027-A | Method for preparing high molecular weight polyacrylamide dried powder | 许振举 | 2004-11-03 | — | — | CN | disclosed |
| CN-1486367-A | Novel fructosyl amino acid oxidase | ������������ʽ���� | 2004-03-31 | — | — | CN | disclosed |
| CN-1095767-C | Balloon fluid supply catheter device and balloon system | MCALISTER ROY (US) | 2002-12-11 | — | — | CN | disclosed |
| CN-1171341-A | Emergency protection method and device | ROY MCALISTER (US) | 1998-01-28 | — | — | CN | disclosed |
| CN-1095923-A | pharmaceutical composition | SMITHKLINE BEECHAM PLC (GB) | 1994-12-07 | — | — | CN | disclosed |
| CN-1024497-C | Pharmaceutical formulations | SMITH KLINE FRENCH LAB (GB) | 1994-05-18 | — | — | CN | disclosed |
| CN-87105387-A | Pharmaceutical composition and preparation method thereof | — | 1988-02-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030903-B2 | Antiviral compounds | EIF2AK2, MAVS, DUT | CA1 4883/4885CA2 4733/4885CA9 3999/4885 |
| US-20250002513-A1 | ANTIVIRAL COMPOUNDS | EIF2AK2, MAVS, DUT | CA1 4883/4885CA2 4733/4885CA9 3999/4885 |
| US-20220289734-A1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | CASP3, BAX, CASP2 | CA1 4326/4885CA2 4318/4885CA9 4861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.